News

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...
Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...
Pfizer and Astellas Pharma have shared positive top-line results from a late-stage study of their androgen receptor signalling inhibitor Xtandi (enzalutamide) in a subset of prostate cancer patients.
Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...
Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...
In 2008, the largest automotive recall in history occurred when Takata Corp. air bags in several brands of cars were found to ...
In 2022, over 1 billion people were affected by obesity, driving innovation in therapeutic advancements. Emerging treatments focus on appetite control and metabolic pathways, with pharmaceutical ...
Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...
A study of 1.2 million Danish children found no link between vaccines containing aluminum and an elevated risk for 50 ...